-
-
封面介绍On the cover: An injectable silk fibroin hydrogel with encapsulated SBA-15 for the co-delivery of a vascular disrupting agent, combretastatin A4 disodium phosphate (CA4P), and a chemotherapeutic agent, doxorubicin hydrochloride (DOX), was prepared. Such hydrogels showed two different types of drug release behavior and held great potential for drug delivery and tumor therapy. [Zhengzhong Shao et al. on page 1023-1029.]
-
-
本期栏目
目录
综述
研究论文
书评